MLTX vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 18, 2026

MLTX

50.9
AI Score
VS
SYRE Wins

SYRE

69.5
AI Score

Investment Advisor Scores

MLTX

51score
Recommendation
HOLD

SYRE

70score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MLTX SYRE Winner
Net Income -131.51M -155.20M MLTX
Operating Income -131.69M -209.56M MLTX
ROE -30.7% -21.7% SYRE
ROA -22.9% -20.0% SYRE
Total Assets 573.95M 777.78M SYRE
Cash 477.90M 85.72M MLTX
Current Ratio 12.56 13.25 SYRE

Relative Price Performance (Last 90 Days)

MLTX 1M: -26.0% · 3M: -40.9% SYRE 1M: +6.4% · 3M: +4.3%

Current Technical Phase

MLTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 27

RSI (14): 27.0 · Price: $11.15

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.3 · Price: $92.60

Fundamentals Snapshot

Metric MLTX SYRE
Market Cap — —
Forward P/E -3.5 -25.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -3.84 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.